Haita Makanji

Haita Makanji serves as the Vice President of Specialty Clinical Strategy and Innovation at Prime Therapeutics since December 2022. Prior to this role, Haita held various leadership positions at Magellan Rx Management, including Vice President of Specialty Clinical Strategy and Innovation and Vice President of Clinical Specialty Solutions, from April 2014 to September 2024. Additional experience includes serving as President of the Northeast Affiliate of AMCP from April 2019 to April 2020, and working as a Manager in different capacities at CDMI Health and CDMI, LLC from March 2012 to September 2012. Haita earned a Doctor of Pharmacy (PharmD) degree from the Massachusetts College of Pharmacy and Health Sciences, completing studies from January 2007 to January 2011, and has prior education from the University of Connecticut from January 2004 to January 2007.